ZYME FY 2023 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$76M-81.6% YoY

Gross Profit

-$67M-88.1% margin

Operating Income

-$138M-181.6% margin

Net Income

-$119M-156.1% margin

EPS (Diluted)

$-1.72

Cash Flow

Operating Cash Flow

-$118M

Free Cash Flow

-$122M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$581M

Total Liabilities

$116M

Stockholders' Equity

$465M

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$412M	-81.6%
Gross Profit	-$67M	$412M	-116.2%
Operating Income	-$138M	$131M	-205.8%
Net Income	-$119M	$124M	-195.4%